Iterative Health

📍 Cambridge, United States🗓 Founded 2017👥 155 employees💰 Last funded Jan 2022
Software Development🌐 iterative.health
Website LinkedIn
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
6
Total investors
2
Early stage
4
Mid stage
0
Late stage
2017
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
United States
3
Germany
1
Singapore
1
Korea
1
Investor activity2018–2022 · investors recorded per year
201822021320221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Iterative Health?
Iterative Health has 6 investors on record on gritt.io, including 2 early-stage backers, 4 mid-stage.
When did Iterative Health last raise funding?
The most recent investment in Iterative Health recorded on gritt.io was in January 2022.
When was Iterative Health founded?
Iterative Health was founded in 2017.
What industry is Iterative Health in?
Iterative Health operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Iterative Health based?
Iterative Health is headquartered in Cambridge, United States.